Nesa Medtech pioneers a scar-less solution for uterine fibroids

October 13: Nesa Medtech, a medical device startup, has developed a novel scar-less solution for treating symptomatic uterine fibroids. It is the result of extensive research for many years. The procedure involves shrinking the fibroids using thermal energy performed under patented real-time image guidance and navigation system.

Medication is the first line of treatment; unfortunately, it is effective only in a small subset, i.e., less than 25% of cases. This makes the various surgical procedure the solution to treat fibroids. Unfortunately, hysterectomy, i.e., removal of the uterus, is the most common solution. This procedure is considered a major surgery that needs a long recovery time, usually a few weeks and has very high morbidity.  

There is a huge clinical need for an alternative to the current surgical method that significantly reduces the risks associated with the remedy of uterine fibroids. This is where the Nesa Medtech solution comes in. The scar-less solution promotes quicker recovery, has no surgical infection risk, and preserves the uterus.